Qualification: M.Sc. (Zoology) & Ph.D (Biochemistry- Clinical Immunology) 

Dr. Sanchaita Misra, Ph.D. in Biochemistry (Clinical Immunology) from the University of Calcutta (2014-2023), is a life science researcher with over 8 years of experience in immunoblotting, confocal microscopy, and immunocytochemistry, specializing in chronic diseases like rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and oral cancer (OSCC-GB). She explores the dual role of DNT cells in oral cancer immunotherapy. Her expertise includes cell culture, flow cytometry, scRNA-seq data analysis, and animal models, with notable publications on anti-rheumatoid arthritis bioactive and IL-17 as a biomarker. She previously holds an ICMR-Senior Research Fellowship (2019). 

Thrust Area:  

• Rheumatoid Arthritis and Angiogenesis 
• Oral Cancer Immunotherapy 
• Antioxidant Therapies and Oxidative Stress 
• Tumor Biopsy and Molecular Analysis 
• Chronic inflammatory diseases 
• Cancer immunology and therapeutic innovation 

Publications (10) :

1. Misra, S., Mondal, S., Chatterjee, S., Guin, A., Sinhamahapatra, P., & Ghosh, A. (2018). Association of angiogenic and inflammatory markers with power Doppler ultrasound vascularity grade and DAS28-CRP in early rheumatoid arthritis: A comparative analysis. BioMed Research International, 2018, 1–8.  
2. Saha, A., Bagchi, A., Chatterjee, S., Dutta, S., Misra, S., Bhattacharjee, D., Chatterjee, S., Mondal, S., Ghosh, P., Chatterjee, M., & Ghosh, A. (2020). Phenotypic characterization of circulating endothelial cells induced by inflammation and oxidative stress in ankylosing spondylitis. Free Radical Research, 55(1), 1–3.  
3. ​​​​​​​Chatterjee, S., Bhattacharjee, D., Misra, S., Saha, A., Bhattacharyya, N. P., & Ghosh, A. (2020). Increase in MEG3, MALAT1, NEAT1 significantly predicts the clinical parameters in patients with rheumatoid arthritis. Personalized Medicine, 17(6), 445–457. 
4. ​​​​​​​Guin, A., Sinhamahapatra, P., Misra, S., Mazumder, S. R., Chatterjee, S., & Ghosh, A. (2019). Incidence and effect of insulin resistance on progression of atherosclerosis in rheumatoid arthritis patients of long disease duration. Biomedical Journal, 42(6), 394–402.  
5. ​​​​​​​Misra, S., Bagchi, A., Sarkar, A., Niyogi, S., Bhattacharjee, D., Chatterjee, S., Mondal, S., Chattopadhyay, A., Saha, A., Chatterjee, S., Sinhamahapatra, P., Chakrabarti, P., Chatterjee, M., & Ghosh, A. (2021). Methotrexate and theaflavin-3,3'-digallate synergistically restore the balance between apoptosis and autophagy in synovial fibroblasts of RA: An ex vivo approach with cultured human RA FLS. Inflammopharmacology, 29(5), 1427–1442. https://doi.org/10.1007/s10787-021-00857-0 
6. Misra, S., Mondal, S., Chatterjee, S., Dutta, S., Sinha, D., Bhattacharjee, D., Lahiri, D., & Ghosh, A. (2022). Interleukin-17 as a predictor of subclinical synovitis in the remission state of rheumatoid arthritis. Cytokine, 153, 155837. https://doi.org/10.1016/j.cyto.2022.155837 
7. Mazumder, S. R., Misra, S., Guin, A., Paul, D. P., Chatterjee, M., & Ghosh, A. (2016). Immunomodulatory activity of black tea extract in rheumatoid arthritis: An in vitro study. International Journal of Advanced Research, 2(10), 5–11. 
8. Misra, S., Ikbal, A. M., Bhattacharjee, D., Hore, M., Mishra, S., Karmakar, S., Ghosh, A., Srinivas, R., Das, A., Agarwal, S., & Saha, K. D. (2022). Validation of antioxidant, antiproliferative, and in vitro anti-rheumatoid arthritis activities of epigallocatechin-rich bioactive fraction from Camellia sinensis var. assamica, Assam variety white tea, and its comparative evaluation with green tea fraction. Journal of Food Biochemistry, 46(12), e14487.  
​​​​​​​9. Bhattacharjee, D., Mondal, S., Saha, A., Misra, S., Chatterjee, S., Rao, A., Sarkar, A., Chatterjee, S., Sinhamahapatra, P., & Ghosh, A. (2023). Effect of vasodilator and immunosuppressive therapy on the endothelial dysfunction in patients with systemic sclerosis. Clinical and Experimental Medicine, 23(3), 905–915.